Article Details

MorphoSys expands oncology pipeline with $1.7bn acquisition of Constellation Pharmaceuticals

Retrieved on: 2021-06-03 11:48:45

Tags for this article:

Click the tags to see associated articles and topics

MorphoSys expands oncology pipeline with $1.7bn acquisition of Constellation Pharmaceuticals. View article details on hiswai:

Excerpt

German biopharma company MorphoSys has announced that it will acquire Constellations Pharmaceuticals, a clinical-stage company with expertise ...

Article found on: www.pmlive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up